|
gptkbp:instanceOf
|
gptkb:Research_Institute
|
|
gptkbp:aimsTo
|
Improve Mental Health
Enhance_Drug_Development
|
|
gptkbp:collaboratesWith
|
Universities
Healthcare Organizations
|
|
gptkbp:conducts
|
Clinical Trials
|
|
gptkbp:contributedTo
|
Scientific_Community
|
|
gptkbp:develops
|
New Medications
|
|
gptkbp:employs
|
Researchers
Scientists
|
|
gptkbp:focusesOn
|
Mental Disorders
Pharmaceutical_Research
|
|
gptkbp:foundedIn
|
2009
|
|
gptkbp:hasCollaborationsWith
|
Biotech_Firms
|
|
gptkbp:hasFacilities
|
gptkb:Cambridge
gptkb:London
|
|
gptkbp:hasPartnershipsWith
|
Research Institutions
Pharmaceutical Companies
|
|
gptkbp:hasResearchFocus
|
Neurodegenerative Diseases
Cognitive Disorders
|
|
gptkbp:hasResearchInterest
|
Parkinson's Disease
Depression
Anxiety
Schizophrenia
Alzheimer's Disease
|
|
gptkbp:historicalResearch
|
Scientific Journals
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lundbeck Research UK
|
|
gptkbp:isActiveIn
|
Drug Discovery
Clinical_Research
|
|
gptkbp:isEngagedIn
|
Translational Medicine
|
|
gptkbp:isInvolvedIn
|
Health Policy
Patient Advocacy
|
|
gptkbp:isKnownFor
|
Innovative_Research
|
|
gptkbp:isLocatedIn
|
gptkb:UK
|
|
gptkbp:isPartOf
|
Global_Research_Network
|
|
gptkbp:isRecognizedFor
|
Scientific Excellence
|
|
gptkbp:isSupportedBy
|
gptkb:Lundbeck_A/S
|
|
gptkbp:location
|
gptkb:United_Kingdom
|
|
gptkbp:parentCompany
|
gptkb:Lundbeck_A/S
|
|
gptkbp:participatesIn
|
International_Conferences
|
|
gptkbp:partOf
|
gptkb:Lundbeck_A/S
|
|
gptkbp:receivesFundingFrom
|
gptkb:Lundbeck_A/S
|
|
gptkbp:specializesIn
|
Neurology
|
|
gptkbp:utilizes
|
Advanced_Technologies
|